In a new report, SmarTech Markets Publishing forecasts shipments of 3-D printers in the medical industry will reach 2,135 units in 2020, growing to 3,055 units in 2024. The report, "3-D Printing in Medical Markets: An Opportunity Analysis and Ten-Year Forecast," shows where opportunities will be found.

AirStrip and Life Monitor Pty Ltd. announced the formation of a strategic partnership to sell AirStrip solutions in Australia and New Zealand. Both the AirStrip ONE mobile interoperability platform and the Sense4Baby wireless fetal/maternal monitoring system will be available as part of the agreement.

MarketReportsOnline.com adds "Global Radiation Therapy Market Report: 2015 Edition" report that says worldwide radiation therapy market has shown significant growth over the past few years, with North America as the highly competitive and largest market for radiotherapy devices.

By loading magnetic nanoparticles with drugs and dressing them in biochemical camouflage, Houston Methodist researchers say they can destroy blood clots 100 to 1,000 times faster than a commonly used clot-busting technique. The finding, reported in Advanced Functional Materials, is based on experiments in human blood and mouse clotting models.

Investigators from Dartmouth College’s Norris Cotton Cancer Center have discovered how the complex parts of the blue light known as the Cherenkov effect can be measured and used in dosimetry to make radiation therapies safer and more effective. Findings of the study, led by Brian W. Pogue, Ph.D., and Ph.D. candidates Adam K. Glaser and Rongxiao Zhang, were published in the journal Physics in Medicine and Biology.

Viztek, a leading provider of complete digital software and hardware diagnostic imaging solutions, has announced today record sales and continued demand for its ViZion + Wireless DR panel. Viztek has sold more than 300 ViZion + Wireless DR panels since the product became commercially available in early November, less than four months ago.

Kennedy Health has selected Mach7 Technologies’ vendor neutral archive (VNA), Enterprise Imaging Platform and zero-footprint universal Clinical Viewer. The selection caps a year-long intensive vendor evaluation.

SuperSonic Imagine announced a partnership with U.S.-based Unetixs Vascular Inc. to bring SuperSonic Imagine’s technology to more customers in the vascular market.

Physicians treating patients with complex tumors will have more advanced treatment options at Seattle Cancer Care Alliance Proton Therapy, a ProCure Center. The center will now offer pencil beam scanning (PBS) in its state-of-the-art gantry room. The combination of proton therapy with PBS technology enables physicians to better shape and direct radiation to the tumor, opening the doors to treat a wider variety of cancers.

Accuray Inc. and Lancaster General Health announced that the first commercially available InCise multileaf collimator (MLC) for the CyberKnife M6 System has been received by Lancaster. The hospital selected the InCise MLC based on its ability to increase the system's treatment efficiency and extend its unique capabilities to a broader range of patient cases.